BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27546709)

  • 1. The ABC Method and Gastric Cancer: Evidence From Prospective Studies.
    Sasazuki S
    J Epidemiol; 2016 Dec; 26(12):611-612. PubMed ID: 27546709
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study.
    Ikeda F; Shikata K; Hata J; Fukuhara M; Hirakawa Y; Ohara T; Mukai N; Nagata M; Yoshida D; Yonemoto K; Esaki M; Kitazono T; Kiyohara Y; Ninomiya T
    J Epidemiol; 2016 Dec; 26(12):629-636. PubMed ID: 27265836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels--The ABC Method.
    Yamaguchi Y; Nagata Y; Hiratsuka R; Kawase Y; Tominaga T; Takeuchi S; Sakagami S; Ishida S
    Digestion; 2016; 93(1):13-8. PubMed ID: 26789514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gastric cancer screening using ABC classification].
    Inoue K
    Nihon Rinsho; 2012 Oct; 70(10):1790-4. PubMed ID: 23198563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels.
    Yanaoka K; Oka M; Yoshimura N; Mukoubayashi C; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Yamamichi N; Fujishiro M; Takeshita T; Mohara O; Ichinose M
    Int J Cancer; 2008 Aug; 123(4):917-26. PubMed ID: 18508314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: changes in the risk with extended follow-up period.
    Knekt P; Teppo L; Aromaa A; Rissanen H; Kosunen TU
    Int J Cancer; 2006 Aug; 119(3):702-5. PubMed ID: 16496404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Strategies for extermination of gastric cancer from Japan].
    Asaka M
    Nihon Rinsho; 2011 Jan; 69(1):173-82. PubMed ID: 21226280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of Helicobacter pylori -negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy.
    Ono S; Kato M; Suzuki M; Ishigaki S; Takahashi M; Haneda M; Mabe K; Shimizu Y
    Digestion; 2012; 86(1):59-65. PubMed ID: 22722747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for Helicobacter pylori infection and gastroduodenal diseases.
    Shiota S; Yamaoka Y
    Biomark Med; 2014; 8(9):1127-37. PubMed ID: 25402582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Useful clinical laboratory tests for early diagnosis of gastrointestinal diseases].
    Ishino Y; Sugano K
    Nihon Naika Gakkai Zasshi; 2005 Dec; 94(12):2508-13. PubMed ID: 16419591
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm.
    Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
    J Dig Dis; 2014 Jun; 15(6):293-8. PubMed ID: 24602176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
    Leja M; Cine E; Rudzite D; Vilkoite I; Huttunen T; Daugule I; Rumba-Rozenfelde I; Pimanov S; Liepniece-Karele I; Pahomova J; Purmalis K; Eglitis J; Pirags V; Dzerve V; Erglis A
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk of gastric cancer dependent on serological markers of atrophic gastritis: cohort study].
    Reshetnikov OV; Openko TG; Simonova GI; Kurilovich SA; Maliushina SK; Ragino IuI; Voevoda MI
    Vopr Onkol; 2012; 58(5):644-8. PubMed ID: 23600281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
    Watanabe M; Kato J; Inoue I; Yoshimura N; Yoshida T; Mukoubayashi C; Deguchi H; Enomoto S; Ueda K; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Tekeshita T; Mohara O; Ushijima T; Ichinose M
    Int J Cancer; 2012 Dec; 131(11):2632-42. PubMed ID: 22383377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of diffuse carcinomas in the gastric corpus in patients with rugal hyperplastic gastritis.
    Fossmark R; Waldum H
    Int J Cancer; 2013 Nov; 133(9):2260. PubMed ID: 23613381
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between serum pepsinogen A and C levels, serum gastrin concentrations and Helicobacter pylori antibodies.
    Kullich W; Pöllmann G; Czerwenka C; Klein G
    Wien Med Wochenschr; 1999; 149(7):157-61. PubMed ID: 10413837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiopathology of Helicobacter pylori infection: Pepsinogen secretion].
    Urita Y; Miki K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():235-9. PubMed ID: 11979784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.